NCT05839756

Brief Summary

Endotracheal intubation can induce laryngotracheal injury which results in narrowing of the airway due to edema of the glottis. This can increase the risk of development of post-extubation stridor (PES)

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
26mo left

Started May 2023

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress58%
May 2023Jun 2028

First Submitted

Initial submission to the registry

April 21, 2023

Completed
12 days until next milestone

First Posted

Study publicly available on registry

May 3, 2023

Completed
Same day until next milestone

Study Start

First participant enrolled

May 3, 2023

Completed
4.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 25, 2028

Expected
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2028

Last Updated

February 17, 2026

Status Verified

February 1, 2026

Enrollment Period

4.8 years

First QC Date

April 21, 2023

Last Update Submit

February 15, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Laryngeal air column width ratio

    %

    immediately before extubation

Secondary Outcomes (4)

  • The duration of nasal endotracheal intubation

    Procedure (from nasal endotracheal intubation till extubation)

  • endotracheal tube insertion depth

    immediately after intubation

  • The incidence of epistasis occurrence during nasotracheal intubation

    immediately after intubation

  • Expiratory tidal volume immediate after intubation with the cuff inflated

    immediately after intubation

Other Outcomes (9)

  • Expiratory tidal volume immediate after intubation with the cuff deflated

    immediately after intubation

  • Expiratory tidal volume immediate before extubation with the cuff inflated

    immediately before extubation

  • Expiratory tidal volume immediate before extubation with the cuff deflated

    immediately before extubation

  • +6 more other outcomes

Study Arms (2)

control (C) group

PLACEBO COMPARATOR

normal saline will be nebulized

Drug: normal saline

Budesonide (B) group

ACTIVE COMPARATOR

budesonide will be nebulized

Drug: budesonide

Interventions

2 ml nebulized budesonide (containing 1 mg) diluted in 3 ml of normal saline will be nebulized preoperatively

Budesonide (B) group

5 ml normal saline will be nebulized preoperatively

control (C) group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult patients (\>18 years)
  • American Society of Anesthesiologists status I and II
  • undergoing elective maxillomandibular fixation surgeries under general anesthesia with nasal endotracheal intubation

You may not qualify if:

  • patients' refusal
  • pregnant females
  • patients with body mass index \<18.5 or ≥ 35 kg/m2
  • risk of aspiration
  • cardiorespiratory disorder
  • neuromuscular disease
  • uncontrolled diabetes mellitus
  • gastrointestinal bleeding
  • on chronic steroid therapy
  • intubated patients or were intubated or had upper airway infection within 1 week prior to surgery
  • history of any pathology, radiotherapy or surgery in the neck
  • had difficult laryngeal US plane (as neck wound)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maha Ahmed AboZeid

Al Mansurah, Mansoura, 35511, Egypt

RECRUITING

MeSH Terms

Conditions

Respiratory SoundsLaryngeal Edema

Interventions

BudesonideSaline Solution

Condition Hierarchy (Ancestors)

Signs and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and SymptomsLaryngeal DiseasesRespiratory Tract DiseasesOtorhinolaryngologic Diseases

Intervention Hierarchy (Ancestors)

PregnenedionesPregnenesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsCrystalloid SolutionsIsotonic SolutionsSolutionsPharmaceutical Preparations

Central Study Contacts

Maha A AboZeid, MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Masking Details
The preoperative aerosolized drug will be applied by an anesthetist who is not involved in further patient care
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Patients will be randomly allocated into two equal groups via opaque coded envelopes
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Anesthesia and Surgical Intensive Care

Study Record Dates

First Submitted

April 21, 2023

First Posted

May 3, 2023

Study Start

May 3, 2023

Primary Completion (Estimated)

February 25, 2028

Study Completion (Estimated)

June 30, 2028

Last Updated

February 17, 2026

Record last verified: 2026-02

Locations